Adrienne Farid Century Therapeutics, Inc. (IPSC) insider trading activity

Adrienne Farid is Chief Operations Officer of Century Therapeutics, Inc.. Currently has a direct ownership of 250,141 shares of IPSC, which is worth approximately $130,073. The most recent transaction as insider was on Jun 09, 2025, when has been sold 552 shares (Common Stock) at a price of $0.62 per share, resulting in proceeds of $342. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 250K

0.22% 3M change

83.71% 12M change

Total Value Held $130,073

Adrienne Farid Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 09 2025	SELL Open market or private sale	$342 $0.62 p/Share	552 Reduced 0.22%	250,141 Common Stock
May 05 2025	SELL Open market or private sale	$563 $0.55 p/Share	1,024 Reduced 0.41%	250,693 Common Stock
Mar 11 2025	BUY Grant, award, or other acquisition	-	120,000 Added 32.28%	251,717 Common Stock
Mar 10 2025	SELL Open market or private sale	$1,462 $0.62 p/Share	2,359 Reduced 1.76%	131,717 Common Stock
Feb 03 2025	SELL Open market or private sale	$822 $0.78 p/Share	1,054 Reduced 0.78%	134,076 Common Stock
Nov 04 2024	SELL Open market or private sale	$1,270 $1.23 p/Share	1,033 Reduced 0.76%	135,130 Common Stock
Aug 05 2024	SELL Open market or private sale	$1,963 $1.83 p/Share	1,073 Reduced 0.78%	136,163 Common Stock
May 03 2024	SELL Open market or private sale	$2,839 $3.11 p/Share	913 Reduced 0.66%	137,236 Common Stock
Mar 07 2024	SELL Open market or private sale	$117,351 $5.14 p/Share	22,831 Reduced 16.67%	114,149 Common Stock
Mar 07 2024	BUY Grant, award, or other acquisition	-	24,000 Added 14.8%	138,149 Common Stock
Mar 07 2024	BUY Exercise of conversion of derivative security	$23,515 $1.03 p/Share	22,831 Added 14.29%	136,980 Common Stock
Mar 06 2024	SELL Open market or private sale	$152,192 $4.96 p/Share	30,684 Reduced 21.19%	114,149 Common Stock
Mar 06 2024	BUY Exercise of conversion of derivative security	$31,604 $1.03 p/Share	30,684 Added 17.48%	144,833 Common Stock
Feb 16 2024	SELL Open market or private sale	$2,357 $4.86 p/Share	485 Reduced 0.42%	114,149 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	$499 $1.03 p/Share	485 Added 0.42%	114,634 Common Stock
Feb 06 2024	SELL Open market or private sale	$8,010 $4.49 p/Share	1,784 Reduced 1.54%	114,149 Common Stock
Feb 05 2024	SELL Open market or private sale	$7,814 $3.84 p/Share	2,035 Reduced 1.73%	115,933 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	43,750 Added 27.05%	117,968 Common Stock

Adrienne Farid

Chief Operations Officer

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IPSC shares.

Notify only if

Value

Insider Trading

Get notified when an Century Therapeutics, Inc. insider buys or sells IPSC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Century Therapeutics, Inc.

Track Activities on IPSC

Account